• Ülevaade
  • Rasvumise levimus
  • Rahvastiku jaotus
  • Tegurid
  • Kaasnevad haigused
  • Strateegiad
Info laeb. Palun oodake!

Rasvumise levimus

Täiskasvanud, 2010

Uuringu tüüp:Mõõdetud
Vanus:18-64
Valimi suurus:3368
Hõlmatud piirkond:Riiklik
Viited:French Polynesia STEPS Survey 2010
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Täiskasvanud, 2007-2008

Uuringu tüüp:Mõõdetud
Vanus:15+
Valimi suurus:605
Hõlmatud piirkond:Riiklik
Viited:Daigre J-L, et al. The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: The PODIUM survey. Diabetes Metab (2012), http://dx.doi.org/10.1016/j.diabet.2012.03.008
Märkused:Small sample size
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Lapsed, 2024

Uuringu tüüp:Ise teatatud
Vanus:13-17
Valimi suurus:3118
Hõlmatud piirkond:Riiklik
Viited:2024 GSHS Fact Sheet French Polynesia. Available at: https://www.who.int/publications/m/item/2024-gshs-fact-sheet-french-polynesia (Accessed: 12.06.25)
Cutoffs:WHO 2007

Lapsed, 2015

Uuringu tüüp:Ise teatatud
Vanus:13-17
Valimi suurus:3216
Hõlmatud piirkond:Riiklik
Viited:Global School-based Student Health Survey (GSHS), available at https://www.who.int/ncds/surveillance/gshs/gshs_fs_french_polynesia_2015.pdf?ua=1 (last accessed 14.12.20)
Cutoffs:WHO

Ülekaalulisus / rasvumine vanuse järgi

Täiskasvanud, 2010

Uuringu tüüp:Mõõdetud
Hõlmatud piirkond:Riiklik
Viited:French Polynesia STEPS Survey 2010. https://extranet.who.int/ncdsmicrodata/index.php/catalog/662/download/4775 (Accessed 04.01.23)
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Lapsed, 2015

Uuringu tüüp:Mõõdetud
Valimi suurus:3216
Hõlmatud piirkond:Riiklik
Viited:Global School-based Student Health Survey. French Polynesia 2015 Fact Sheet. https://extranet.who.int/ncdsmicrodata/index.php/catalog/657/download/4725 (Accessed 04.01.2023)
Cutoffs:WHO

Double burden of underweight & overweight

Täiskasvanud, 2022

Uuringu tüüp:Mõõdetud
Vanus:20+
Viited:NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2.
Märkused:Age Standardised estimates
Mõisted:Combined prevalence of BMI<18.5 kg/m² and BMI>=30 kg/m² (double burden of underweight and obesity)

Lapsed, 2022

Uuringu tüüp:Mõõdetud
Vanus:5-19
Viited:NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. Lancet 2024; published online Feb 29. https://doi.org/10.1016/S0140-6736(23)02750-2.
Märkused:Age standardised estimates
Mõisted:Combined prevalence of BMI < -2SD and BMI > 2SD (double burden of thinness and obesity)
Cutoffs:BMI < -2SD and BMI > 2SD

Ebapiisav füüsiline aktiivsus

Täiskasvanud, 2016

Viited:Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7

Mehed, 2016

Viited:Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7

Naised, 2016

Viited:Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet 2018 http://dx.doi.org/10.1016/S2214-109X(18)30357-7

Söögitoruvähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Mehed, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Rinnavähk

Naised, 2022

Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Pärasoolevähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Mehed, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Kõhunäärmevähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Mehed, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Sapipõie vähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000

Mehed, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Neeruvähk

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Mehed, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Naised, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Emakavähk

Naised, 2022

Vanus:20+
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2020-2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2149
Mõisted:Age-standardized indicence rates per 100 000

Diabeedi levimus

Täiskasvanud, 2024

Viited:Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org

Täiskasvanud, 2021

Vanus:20-79
Hõlmatud piirkond:Riiklik
Viited:Reproduced with kind permission International Diabetes Federation.  IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org
Mõisted:Age-adjusted comparative prevalence of diabetes, %

Täiskasvanud, 2019

Vanus:20-79
Viited:Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org
Mõisted:Diabetes age-adjusted comparative prevalence (%).

Täiskasvanud, 2017

Viited:Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org
Mõisted:Diabetes age-adjusted comparative prevalence (%).

Ovarian Cancer

Naised, 2022

Vanus:20+
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Leukemia

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Leukemia

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Liver and intrahepatic bile duct Cancer

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Multiple Myeloma

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Indicence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Non Hodgkin Lymphoma

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000
Kui ei ole märgitud teisiti, tähendab ülekaal KMI vahemikku 25 kg ja 29,9 kg/m², rasvumine KMI-t üle 30 kg/m².

Thyroid Cancer

Mehed, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Naised, 2022

Vanus:20+
Hõlmatud piirkond:Riiklik
Viited:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Mõisted:Incidence per 100,000

Policies, Interventions and Actions

Polynesian action programne on a balanced diet and physical activity

The policy documents set how NCDs will be addressed in French Polynesia, particularly through action on diet and physical activity.

Categories:Evidence of Nutritional or Health Strategy/ Guidelines/Policy/Action plan
Evidence of Physical Activity Guidelines/Policy
Year(s):2019-2023
Target age group:Täiskasvanud ja lapsed
Organisation:Ministry of Health and Prevention
Linked document:Download linked document

Prevention and health promotion plan for French Polynesia

The policy sets out how to create a healthy environment in French Polynesia so that healthy choices are easier to make.

Categories:Evidence of Nutritional or Health Strategy/ Guidelines/Policy/Action plan
Year(s):2018-2022
Target age group:Täiskasvanud ja lapsed
Organisation:Ministry of Solidarity and Health
Linked document:Download linked document

Action Plan to Reduce the Double Burden of Malnutrition in the Western Pacific Region (2015–2020)

The WHO action plan to reduce the double burden of malnutrition in the Western Pacific Region. It calls for accelerated efforts to improve nutrition. The plan includes targets to halt the increase in childhood overweight and adult and adolescent diabetes and obesity by 2025.

Categories:Evidence of National Obesity Strategy/Policy or Action plan
Evidence of Nutritional or Health Strategy/ Guidelines/Policy/Action plan
Evidence of Obesity Target
Year(s):2015-2020
Target age group:Lapsed
Organisation:World Health Organisation
Find out more:www.who.int
Linked document:Download linked document
References:World Health Organization. 2015. Action plan to reduce the double burden of malnutrition in the Western Pacific Region (2015–2020).

No actions could be found for the above criteria.

Feedback

Are you finding the information on these pages useful?
Yes
No
N/A

Thank you for feeding back to World Obesity.

If you have any further feedback or suggestions please email us at obesity@worldobesity.org.

Close
Loading